This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: DIS GILD NFLX ONXX STZ

Sonoco Products (DA) downgraded at DA Davidson to Neutral, DA Davidson said. $33 price target. Estimates also cut, given the company's new guidance.

Webster Financial (WBS) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $24 price target. Company is leveraged to higher expected mortgage prepay rates.

Western Gas Partners (WES) downgraded at UBS to Neutral from Buy, UBS said. $51 price target. Valuation call.


Allegiant Travel (ALGT) estimates raised at UBS through 2013, UBS said. Solid guidance for Q3. Buy rating and $75 price target.

Cabela's (CAB) estimates, target boosted at Credit Suisse. Shares of CAB now seen reaching $62, according to Credit Suisse. Estimates also upped, given higher expected comp sales. Outperform rating.

Community Health Systems (CYH) target raised at Jefferies to $29, Jefferies said. Easy 2H12 comps and discounted valuation could ignite upward momentum. Hold rating.

Medtronic (MDT) target raised at Oppenheimer to $48, Oppenheimer said. Recent peer-group multiple expansion. Outperform rating.

Northern Trust (NTRS) numbers lowered at Jefferies. Shares of NTRS now seen reaching $48, Jefferies said. Estimates also lowered on efficiency initiatives. Hold rating.

Ocwen Financial (OCN) numbers raised at KBW. Shares of OCN now seen reaching $40, according to Keefe, Bruyette & Woods said. Homeward acquisition should add to earnings. Outperform rating.

Onyx Pharmaceuticals (ONXX) numbers increased at BofA/Merrill. ONXX estimates were raised through 2013, Bank of America/Merrill Lynch said. Expect higher Kyprolis sales. Buy rating and new $101 price target.

Constellation Brands (STZ - Get Report) numbers raised at UBS. Shares of STZ now seen reaching $42. Estimates also increased as strong depletion trends support positive outlook. Buy rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ONXX $0.00 0.00%
DIS $103.26 0.00%
GILD $88.21 0.00%
NFLX $90.03 0.00%
STZ $156.06 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs